AAAAAA
Results:
1-7
|
Results: 7
Authors:
Bakhle, YS
Citation: Ys. Bakhle, COX-2 and cancer: a new approach to an old problem, BR J PHARM, 134(6), 2001, pp. 1137-1150
Authors:
Bandeira-Melo, C
Serra, MF
Diaz, BL
Cordeiro, RSB
Silva, PMR
Lenzi, HL
Bakhle, YS
Serhan, CN
Martins, MA
Citation: C. Bandeira-melo et al., Cyclooxygenase-2-derived prostaglandin E-2 and lipoxin A(4) accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: Relationship with concurrent eosinophilia, J IMMUNOL, 164(2), 2000, pp. 1029-1036
Authors:
Campbell, VA
Beddy, P
Foley, A
Bakhle, YS
Bell, C
Citation: Va. Campbell et al., Reduced inflammation in genetically hypertensive rat airways is associatedwith reduced tachykinin NK1 receptor numbers, EUR J PHARM, 401(1), 2000, pp. 109-114
Authors:
Bakhle, YS
Citation: Ys. Bakhle, Nimesulide and COX-2 inhibitors, LANCET, 354(9180), 1999, pp. 772-772
Authors:
Bakhle, YS
Citation: Ys. Bakhle, Structure of COX-1 and COX-2 enzymes and their interaction with inhibitors, DRUGS TODAY, 35(4-5), 1999, pp. 237-250
Authors:
Sprott, H
Bakhle, YS
Botting, J
Prous, JR
Citation: H. Sprott et al., Section 1: Nonsteroidal antiinflammatory agents - Discussion, DRUGS TODAY, 35(4-5), 1999, pp. 403-404
Authors:
Bakhle, YS
Brogan, JD
Bell, C
Citation: Ys. Bakhle et al., Decreased vascular permeability response to substance P in airways of genetically hypertensive rats, BR J PHARM, 126(4), 1999, pp. 933-938
Risultati:
1-7
|